1. |
Jin Y, Yang H, Ji W, et al. Virology, epidemiology, pathogenesis, and control of COVID-19[J]. Viruses, 2020, 12(4): 372. DOI: 10.3390/v1240372.
|
2. |
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China[J]. N Engl J Med, 2020, 382(18): 1708-1720. DOI: 10.1056/NEJMoa2002032.
|
3. |
季樱红, 孙杨, 卢奕. 新型冠状病毒的眼睛侵入途径与眼科防护重点[J]. 中国眼耳鼻喉科杂志, 2020, 20(3): 156-161. DOI: 10.14166/j.issn.1671-2420.2020.03.003.Ji YH, Sun Y, Lu Y. Eye invasion route of 2019 novel corona virus and the emphasis of ophthalmic protection[J]. Chin J Ophthalmol and Otorhinolaryngol, 2020, 20(3): 156-161. DOI: 10.14166/j.issn.1671-2420.2020.03.003.
|
4. |
Lu CW, Liu XF, Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored[J/OL]. Lancet, 2020, 395(10224): e39[2020-02-06]. https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(20)30313-5. DOI: 10.1016/S0140-6736(20)30313-5.
|
5. |
蓝倩倩, 曾思明, 廖欣, 等. 新型冠状病毒肺炎患者中新型冠状病毒相关性结膜炎的筛查[J]. 中华眼科杂志, 2020, 56(6): 433-437. DOI: 10.3760/cma.j.cn112142-20200322-00213.Lan QQ, Zeng SM, Yan X, et al. Screening for novel coronavirus related conjunctivitis among the patients with coronavirus disease 2019[J]. Chin J Ophthalmol, 2020, 56(6): 433-437. DOI: 10.3760/cma.j.cn112142-20200322-00213.
|
6. |
Gaba WH, Ahmed D, Al Nuaimi RK, et al. Bilateral central retinal vein occlusion in a 40-year- old man with severe coronavirus disease 2019 (COVID-19) pneumonia[J/OL]. Am J Case Rep, 2020, 21: e927691[2020-10-29]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603800/. DOI:10.12659/AJCR.927691.
|
7. |
Jalink MB, Bronkhorst IHG. A sudden rise of patients with acute macular neuroretinopathy during the COVID-19 pandemic[J]. Case Rep Ophthalmol, 2022, 13(1): 96-103. DOI: 10.1159/000522080.
|
8. |
Bottini AR, Steinmetz S, Blinder KJ, et al. Purtscher-like retinopathy in a patient with COVID-19[J/OL]. Case Rep Ophthalmol Med, 2021, 2021: 6661541[2021-03-20]. https://europepmc.org/article/MED/33859855. DOI:10.1155/2021/6661541.
|
9. |
中华人民共和国国家卫生健康委员会. 新型冠状病毒感染诊疗方案(试行第十版)[J]. 中华临床感染病杂志, 2023, 16(1): 1-9. DOI: 10.3760/cma.j.issn.1674-2397.2023.01.001.National Health Commission of the People’s Republic of China. Diagnosis and treatment plan for COVID-19 (trial version 10) [J]. Chin J Clin Infect Dis, 2023, 16(1) : 1-9. DOI: 10.3760/cma.j.issn.1674-2397.2023.01.001.
|
10. |
姜利斌, 魏文斌, 王光璐. 急性黄斑区神经视网膜病变[J]. 中国实用眼科杂志, 2006, 24(3): 240-243. DOI: 10.3760/cma.j.issn.1006-4443.2006.03.003.Jiang LB, Wei WB, Wang GL. Acute macular neuroretinopathy[J]. Chin J Pract Ophthalmol, 2006, 24(3): 240-243. DOI: 10.3760/cma.j.issn.1006-4443.2006.03.003.
|
11. |
戴荣平, 董方田, 郑霖, 等. Purtscher样视网膜病变[J]. 中华眼科杂志, 2007, 43(5): 447-450. DOI: 10.3760/j.issn:0412-4081.2007.05.014.Dai RP, Dong FT, Zheng L, et al. Purtscher-like retinopathy[J]. Chin J Ophthalmol, 2007, 43(5): 447-450. DOI: 10.3760/j.issn:0412-4081.2007.05.014.
|
12. |
Ozturker ZK. Conjunctivitis as sole symptom of COVID-19: a case report and review of literature[J]. Eur J Ophthalmol, 2021, 31(2): NP161-NP166. DOI: 10.1177/1120672120946287.
|
13. |
滕岩, 滕羽菲. 急性黄斑区神经视网膜病变的临床特征及病理机制研究进展[J]. 中华眼科杂志, 2019, 55(4): 311-315. DOI: 10.3760/cma.j.issn.0412-4081.2019.04.016.Tang Y, Teng YF. The clinical characteristics and pathologic mechanisms of acute macular neuroretinopathy[J]. Chin J Ophthalmol, 2019, 55(4): 311-315. DOI: 10.3760/cma.j.issn.0412-4081.2019.04.016.
|
14. |
Pang CE, Navajas EV, Warner SJ, et al. Acute macular neuroretinopathy associated with chikungunya fever[J]. Ophthalmic Surg Lasers Imaging Retina, 2016, 47(6): 596-599. DOI: 10.3928/23258160-20160601-15.
|
15. |
Bhavsar KV, Lin S, Rahimy E, et al. Acute macular neuroretinopathy: a comprehensive review of the literature[J]. Surv Ophthalmol, 2016, 61(5): 538-565. DOI: 10.1016/j.survophthal.2016.03.003.
|
16. |
Amer R, Lois N. Punctate inner choroidopathy[J]. Surv Ophthalmol, 2011, 56(1): 36-53. DOI: 10.1016/j.survophthal.2010.03.009.
|
17. |
Corver HD, Ruys J, Kestelyn-Stevens AM, et al. Two cases of acute macular neuroretinopathy[J]. Eye (Lond), 2007, 21(9): 1226-1229. DOI: 10.1038/sj.eye.6702543.
|
18. |
Riotto E, Mégevand V, Mégevand A, et al. A COVID-19-related retinopathy case report[J]. Case Rep Ophthalmol, 2022, 13(1): 297-304. DOI: 10.1159/000524195.
|
19. |
D'Souza HS, Tailor PD, Olsen TW. Seeing blue dots after COVID-19 infection[J]. JAMA Ophthamol, 2023, 141(1): 97-98. DOI: 10.1001/jamaophthalmol.2022.5235.
|
20. |
Shroff D, Kumar S, Naidu A, et al. Unilateral purtscher-like retinopathy post-COVID-19[J]. Indian J Ophthalmol, 2022, 70(10): 3710-3712. DOI: 10.4103/ijo.IJO_1486_22.
|
21. |
Kuriakose RK, Chin EK, Almeida DRP. An atypical presentation of acute macular neuroretinopathy after non-ocular trauma[J]. Case Rep Ophthalmol, 2019, 10(1): 1-4. DOI: 10.1159/000496144.
|
22. |
Mbekeani JN, Raval NK, Vo TA, et al. Purtscher-like retinopathy in a patient with COVID-19-associated coagulopathy[J]. Arq Bras Oftalmol, 2022, 85(5): 513-516. DOI: 10.5935/0004-2749.2020-0328.
|
23. |
Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals[J]. Ocul Immunol Inflamm, 2020, 28(3): 391-395. DOI: 10.1080/09273948.2020.1738501.
|
24. |
Zhang H, Penninger JM, Li Y, et al. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target[J]. Intensive Care Med, 2020, 46(4): 586-590. DOI: 10.1007/s00134-020-05985-9.
|
25. |
Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia[J]. J Thromb Haemost, 2020, 18(4): 844-847. DOI: 10.1111/jth.14768.
|
26. |
Landecho MF, Yuste JR, Gándara E, et al. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease?[J]. J Intern Med, 2021, 289(1): 116-120. DOI: 10.1111/joim.13156.
|